Cognition Therapeutics In... (CGTX)
NASDAQ: CGTX
· Real-Time Price · USD
0.30
0.00 (1.59%)
At close: Jun 09, 2025, 3:59 PM
1.59% (1D)
| Bid | 0.3 |
| Market Cap | 18.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -33.3M |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -0.41 |
| Forward PE | -1.04 |
| Analyst | Buy |
| Ask | 0.32 |
| Volume | 864,811 |
| Avg. Volume (20D) | 1,080,985 |
| Open | 0.30 |
| Previous Close | 0.30 |
| Day's Range | 0.30 - 0.30 |
| 52-Week Range | 0.22 - 2.54 |
| Beta | 0.74 |
About CGTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+9.31%
Cognition Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
6 months ago
+27.5%
Cognition Therapeutics shares are trading higher after the company announced topline results which met its primary endpoint of safety and tolerability from its exploratory Phase 2 SHIMMER study.
3 months ago · seekingalpha.com
Cognition Therapeutics, Inc (CGTX) Q4 2024 Earnings Call TranscriptCognition Therapeutics, Inc (NASDAQ:CGTX ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Mike Moyer - LifeSci Advisors Lisa Ricciardi - Chief Executive Officer John Do...